News

Atour Lifestyle: Exceptional Growth in Q3 2024 Earnings

Atour Lifestyle: Exceptional Growth in Q3 2024 Earnings

Atour Lifestyle Holdings Limited Reports Impressive Growth in Third Quarter of 2024

Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a prominent hospitality and lifestyle brand in China, has unveiled its financial results for the third quarter of its fiscal year 2024, showcasing significant advancements in its operations and financial standing. As of the end of September 2024, the company operated 1,533 hotels with a total of 175,199 rooms, marking a year-over-year increase of 37.9% and 36.1% in hotel numbers and room capacity, respectively.

Strong Financial Performance

In terms of financial metrics, Atour reported net revenues of RMB1,899 million (US$271 million) for Q3 2024, which represents a substantial increase of 46.7% compared to RMB1,294 million achieved during the same quarter a year prior. This impressive growth was largely attributed to the expansion of its manachised hotel operations and a surge in retail business performance.

Net Income Gains

The company’s net income also showed robust improvement, climbing by 45.3% to RMB381 million (US$54 million) from RMB262 million in the prior year, reflecting effective cost management and a strong market presence amidst recovery efforts.

Adjusted Financial Metrics

Atour reported an adjusted net income of RMB384 million (US$55 million), representing an increase of 41.2% year-over-year. The EBITDA for the quarter expanded by 42.9%, amounting to RMB529 million (US$75 million), showcasing the efficiency and profitability of operations.

Operational Highlights and Future Outlook

The average daily room rate (ADR) for Atour's hotels was RMB456 during the third quarter of 2024, a decrease from RMB495 in the previous year, while the occupancy rate stood at 80.3%. The revenue per available room (RevPAR) reached RMB380, indicating a strong operational efficiency despite the competitive market landscape.

Looking ahead, Atour anticipates continued growth, expecting total net revenues to surge by approximately 48% to 52% for the full year compared to last year. The company remains focused on a strategic approach that enhances customer experience and leverages innovation in hospitality.

Executive Insight

Mr. Haijun Wang, the Founder, Chairman, and CEO of Atour, commented on the company's performance: “We are excited about our strong finish in the third quarter of 2024, underpinned by synergistic growth across our hotel and retail segments. We opened 140 new hotels this quarter, further expanding our footprint. With the launch of our new upscale brand, SAVHE Hotel, we are establishing a significant presence in the high-end market, poised for future success.”

Commitment to Quality Growth

Atour is dedicated to enhancing its service capabilities and innovating its offerings to deliver premium experiences to its guests. The company is optimistic that these strategic priorities will significantly amplify its brand influence in the competitive landscape of the hospitality industry.

Frequently Asked Questions

What was Atour's revenue for Q3 2024?

Atour reported net revenues of RMB1,899 million (US$271 million) for the third quarter of 2024.

How many hotels does Atour operate currently?

As of September 30, 2024, Atour operates 1,533 hotels.

What is the expected revenue growth for Atour for the full year 2024?

The company expects total net revenues to increase by 48% to 52% compared to the previous year.

Who is the CEO of Atour Lifestyle Holdings Limited?

The CEO is Mr. Haijun Wang, who also serves as the Founder and Chairman of the company.

What is Atour's approach to market expansion?

Atour focuses on strategic expansion through new hotel openings and introducing upscale brand offerings to enhance its market presence.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring Murphy Oil Inc.'s Price-to-Earnings Insights

Updated Category News Views 152

Understanding Murphy Oil Inc.'s Recent Market Performance Currently, Murphy Oil Inc. (NYSE: MUR) shares are valued at $30.88, exhibiting a minor rise of 0.06% in today's trading session. Observing the stock’s journey over the last month, we've seen a significant increase of 6.77%. However, when we take a closer look at the past year, the stock has unfortunately dropped...

Continue Reading
Marco Pharma: 35 Years of Principle Over Profits

Updated Category News Views 3

Keeping Principles Alive in a Competitive Market In an industry where folks often chase the latest trend like seagulls after a fish fry, Marco Pharma International stands its ground on principles rather than profits. It's rare to see a company, especially in the natural health sector, keeping its roots this deep for 35 years. And they're not just talking about it—this...

Continue Reading
Rakovina Therapeutics Unveils AI-Enhanced ATR Inhibitors Breakthrough

Updated Category News Views 188

Rakovina Therapeutics Presents AI-Developed ATR Inhibitors Rakovina Therapeutics Inc. (TSXV: RKV) has made a significant impact at a recent international conference dedicated to cancer therapeutics. The conference gathered numerous leaders in the field, creating an excellent platform to unveil groundbreaking research. Presenting their innovative findings, Rakovina...

Continue Reading
Elon Musk Critiques FCC's Denial of Starlink Subsidy While Aiding Disaster Recovery

Updated Category News Views 334

Elon Musk Critiques FCC's Decision on Starlink Subsidy Elon Musk, the visionary CEO of SpaceX, has voiced his discontent over the FCC's recent ruling that denied approximately $885 million in subsidies to Starlink, the company's satellite internet service. Musk described this decision as "contemptible political lawfare," coinciding with FEMA's deployment of Starlink...

Continue Reading
Assessing the Resilience of American Consumers Amid Challenges

Updated Category News Views 130

Understanding the Current Landscape of American Consumers The state of the American consumer remains resilient despite facing numerous challenges, as reported by Barclays in its recent analysis. The approach to consumer spending in the latest quarter reflects a balancing act, with buyers maneuvering through both advantageous conditions and potential obstacles. Positive...

Continue Reading